Tarextumab (CD52) - Research Grade Biosimilar
Product Specifications
Background
Tarextumab has been used in trials studying the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.
Immunogen
Caninized / CD52 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG2-kappa-lambda
NCBI Organism
Homo sapiens
Other Product Names
OMP-59R5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-12876R-PE-Cy5 100 µL
BOB1 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details 